Brachytherapy is a form of radiotherapy whereby a radiation source is guided near tumors, using devices such as catheter implants. In the present clinical work ow, catheters are rst placed inside or close to the tumor based on clinical expertise. Subsequently, soware is used to design a plan for the delivery of radiation. Treatment planning is essentially a multi-objective optimization problem, where con icting objectives represent radiation delivered to tumor cells and healthy cells. However, current clinical so ware collapses this information into a single-objective, constrained optimization problem. Moreover, catheter positioning is typically not included. As a consequence, it is hard to obtain insight into the true nature of the trade-o s between key planning objectives and the placement of catheters. Such insights are however crucial in understanding how be er treatment plans may be constructed. To obtain such insights, we interface with real-world clinical so ware and derive potential catheter positions for real-world patients. Selecting and con guring catheters requires mixed-integer optimization. For this reason, we extend the recently-proposed Genetic Algorithm for Model-Based mixed-Integer opTimization (GAMBIT) to tackle multi-objective optimization problems. Our results indicate that clinically acceptable plans of high quality may be achievable with less catheters than typically used in current clinical practice.
INTRODUCTION
Prostate cancer is the most common type of cancer among men in the Netherlands, a diagnosis that over 10, 000 men are confronted with each year, and leading to about 2, 500 deaths per year [11] . Radiotherapy is a commonly applied cancer treatment in which ionizing radiation is used to target tumor cells. An important form of radiotherapy for prostate cancer is brachytherapy (BT), where the tumor is irradiated from inside the body by guiding a radiation source close to or inside the tumor. In this paper, we focus on the case whereby catheters are placed in the prostate, for the radiation source to be moved through. Each catheter contains a number of di erent positions, called dwell positions, where the source can dwell for prescribed amounts of time, called dwell times. If the source dwells at a given dwell position, that position is called active; otherwise, it is called inactive. By varying the dwell times, di erent treatment plans are possible.
In determining a treatment plan, there are multiple aspects of importance. Firstly, as many tumor cells as possible should obtain a su ciently high dose in order to maximize the probability of damaging or killing cancer cells. Secondly, the dose to nearby organs cannot be too high, to minimize the probability of complications. Most current clinical so ware for determining a treatment plan is based on single-objective optimization and manual tuning. However, because of the con icting nature of these objectives, multi-objective optimization would be a more natural approach since trade-o s can be shown between the di erent objectives of interest, providing insight into how much may be gained in one objective at what cost to another. is way, a well-informed decision may be taken on what is the best treatment plan for the patient at hand.
Taking also the placement and number of catheters into account in the multi-objective optimization perspective is a natural t, because the exact location of catheters governs much of what may be achieved in terms of plan quality. Moreover, to minimize the possibility of complications, one should use as few catheters as possible [6, 8, 14] . Currently, the placement of catheters is done mostly based on medical expertise. At the hospital involved in this study there are typically 16 − 18 catheters used. Many placements are possible and for each placement many treatment plans are possible, comprising a vast search space. Even though expertise and literature exists on how to place catheters, there is li le information on the real-world trade-o s of catheter placements. Our goal is to take a rst step in this direction, obtaining such insights, learning about the complexity of the multi-objective optimization problem, and start to work toward algorithms that may really be used for patient-speci c optimization in clinical practice. e novelty in our approach is bringing together several aspects that were not considered altogether before. Multi-objective approaches to treatment planning have been proposed, including catheter placement via the weighted-sum method in combination with single-objective optimization, but did not optimize directly on the evaluation criteria of a clinical evaluation protocol [9] . Related work that does optimize on these criteria exists, but is single-objective and does not consider catheter placement [5] . In contrast, we consider the use of realworld clinical so ware and patients combined with multi-objective optimization directly on criteria as considered in clinical evaluation protocols.
From an algorithmic perspective, Evolutionary Algorithms (EAs) are among the state-of-the-art when it comes to solving multiobjective optimization problems [4] . For this reason, we are interested in using an EA to solve this problem. e problem includes both discrete (which catheters) and continuous (dwell times) variables. Many state-of-the-art (multi-objective) EAs focus on either discrete or continuous domains exclusively. Optimization where discrete and continuous variables are present simultaneously is explored relatively less and is referred to as mixed-integer optimization. A recently introduced Genetic Algorithm for Model-Based mixed-Integer opTimization (GAMBIT) has shown to be an e ective approach to single-objective optimization in the mixed-integer domain [12] , especially in the case of black-box optimization, meaning that no internal structure of the problem is assumed to be known in advance. is makes GAMBIT exible and easily adaptable for our multi-objective approach of BT pre-planning optimization. 
BT TREATMENT PLANNING 2.1 Clinical practice
In BT for prostate cancer, the treatment targets are the prostate and the seminal vesicles (see Fig. 1 ). e Organs At Risk (OARs), which should be radiated as li le as possible, are the nearby organs, i.e., bladder, rectum, and urethra. Guided by live ultrasound images, a typical High-Dose-Rate (HDR) prostate BT treatment starts with implanting a number of catheters into the prostate through the patient's perineum skin (between scrotum and anus). e suitable number of catheters and their proper positions depend on the size of the prostate and its geometry in relation to other nearby organs (e.g., bladder and rectum). e inserted catheters need to be rmly xed to prevent displacements. e patient is subsequently transferred to the imaging room, where computed tomography (CT) or Magnetic Resonance Imaging (MRI) scans of the pelvic cavity are acquired.
ese scans are then used to nalize the treatment plan. First, the catheters, the targets, and OARs are delineated on the CT/MRI scans in planning so ware. e doctors then specify which dwell positions in each catheter should be activated. For a given dwell time of a source at a dwell position, more radiation dose is delivered to nearby tissues than to faraway tissues. erefore, to increase the probability of fully treating the target and sparing healthy tissues at the same time, dwell positions inside the target volumes are activated while the ones far away from the targets (e.g., at distances larger than 5mm) or too close to OARs are normally not considered. A trivial treatment plan, in which dwell times take on very large values, can kill all tumor cells but also causes necrosis (i.e., non-physiological cell death) to healthy tissues. On the other hand, another trivial treatment plan, where all dwell times are zero, can e ectively spare healthy tissues from radiation risks but such a plan equals no treatment at all.
A speci c se ing of dwell times delivers a certain radiation dose distribution to the tissues surrounding the catheters. e dose distribution needs to be assessed by doctors to determine if such a se ing can be clinically acceptable. A radiation dose is prescribed for the entire prostate, termed the prescribed dose. Tumor cells, which are more susceptible to radiation than healthy cells, should receive at least the prescribed dose to be e ectively killed. Also, while healthy cells could recover from being radiated at the prescribed dose level, they should not be radiated too much; otherwise, healthy cells would be killed as well. However, it is impossible to compute the exact amount of radiation received by every cell since the number of cells is prohibitively numerous. Dose distributions, therefore, are o en approximated by only computing the radiation dose at a certain number of so-called dose calculation points. Of key interest is how large the cumulative volume of an organ covered by a certain dose is. Such information, termed DoseVolume-Histogram (DVH) indices, can be represented as V o x : the volume (expressed either relatively or absolutely) of organ o that received at least radiation dose level x. For example, international GEC/ESTRO recommendations [7] index equals maximizing the number of dose calculation points inside the prostate that receives at least the prescribed dose. To quickly achieve a result, planning so ware therefore o en solves simpli ed optimization models of the problem with local search methods. It is thus not guaranteed that a treatment plan proposed by available so ware satis es all DVH index criteria in the protocol or that the plan is the best possible one for the patient case at hand. Medical planners then need to manually adjust this proposed plan. ey o en rst consider the DVH index that is violated the most compared to the recommended protocol, and try to nd the locations of violation, then change the dwell times of nearby dwell positions to improve the index until satis ed. ey then continue with a di erent DVH index that is now the most violated. Note that improving a DVH index might deteriorate other indices, including ones that have been previously worked on. e plan is adjusted in such an iterative manner until the doctors are satis ed.
How good the DVH indices can be, depends on the quality of the catheter implant and the geometry of the involved organs. Certain implants will not allow all DVH indices to satisfy the recommended protocol. For example, with too few or improperly placed catheters, it is di cult to obtain V prostate 100 ≥ 95% while meeting constraints on indices of OARs. Similarly, if the rectum is too close to the prostate, V rectum 78 ≤ 1cc and V prostate 100 ≥ 95% might not be achievable at the same time. In such situations, for each speci c case, the doctors need to decide which indices are more important to be satis ed and which indices can be compromised. Final approved treatment plans, thus, might (slightly) violate some clinical protocol thresholds.
Multi-Objective Treatment Planning
BT treatment planning is intrinsically a multi-objective optimization problem. e DVH indices in Table 1 ) and organ sparing indices. Candidate treatment plans that do not achieve the minimum requirements on the indices in the clinical protocol are less favorable than candidate plans that satisfy all protocol thresholds. For a treatment target index, the larger its value is (above the corresponding threshold), the be er it is. For an organ sparing index, the lower its value is (below the corresponding threshold), the be er it is. Optimizing treatment target indices results in increasing dwell times to make the target volumes covered by the treatment dose level as large as possible, where the best value is 100%. On the other hand, optimizing organ sparing indices results in decreasing dwell times to make the organ volumes covered by the radiation risk dose levels as small as possible, where the best value is 0%/0cc. e two groups of DVH indices con ict with each other such that a utopian treatment plan yielding 100% for all target coverage indices and 0%/0cc for all organ sparing indices does not exist. Instead, the optimum of this multi-objective problem is a set (i.e., Pareto-optimal set) of equally-good alternative plans which are optimal in the sense that improving one objective deteriorates the other objective, and vice versa.
ere are nine di erent DVH index criteria. We argue, however, that the clinical protocol can be reformulated to a bi-objective optimization problem without losing key insight into trade-o s by combining the DVH indices of the same group (i.e., target coverage or organ sparing) into a representative objective of that group. To this end, we employ a risk-averse perspective, meaning that a treatment plan is evaluated to be only as good as the worst target coverage index and the worst organ sparing index. More speci cally, each candidate plan has two objective values: the Least Coverage Index (LCI), which corresponds to the worst-scored DVH index in the target coverage group, and the Least Safe Index (LSI), which corresponds to the worst-scored DVH index value in the organ sparing group. erefore, for a speci c treatment plan, all indices in a group are at least as good as the representative value of the group. Such an approach has an analogy with the clinical practice in the iterative focus on improving the current worst index at each time as mentioned previously. Moreover, unlike the weighted-sum approach, where all criteria are added together, each DVH index in our problem modeling is still, in e ect, considered separately. e feasible search space is enlarged to contain solutions that violate the clinical protocol to some degree. ere are two reasons for this. e rst is that, in this way, the clinically-feasible solutions can be approached from both the clinically-feasible and the clinically-infeasible space, making the search in these regions more e cient. Secondly, we account for the fact that sometimes there exists no treatment plan satisfying all clinical protocols (due to the quality of the implants and/or the geometry of the involved organs, see Section 2.1), and a treatment plan that (slightly) violates the protocol must thus be accepted. To relax the clinical constraints, the new upper bounds for organ sparing indices are increased four times (e.g., V e optimization constraints are presented in Table 2 . Let V max x denote the clinical protocol threshold of a dose level x for an organ. To measure and normalize the distance of an organ sparing index value to its corresponding upper bound, we de ne
. e larger the value of δ is, the be er the corresponding DVH index value V x of that organ is and how safe an organ is compared to the relaxed protocol threshold, with a value of 0.75 meaning that the clinical protocol constraint is met. e LSI objective value is de ned as the minimum δ value among all organ sparing indices. Similarly, the LCI objective value of a treatment plan is de ned as the minimum coverage value among all target coverage indices. has become unconstrained.
In this paper, we focus on the pre-planning phase, i.e., before the catheters are inserted. To generate data and problem input that corresponds to real-world clinical practice, we are currently bound to real-world clinical so ware. Given a prostate BT patient, a number of possible catheter con gurations can be determined, a er which the clinical so ware provides information on these possible catheter con gurations and their corresponding dwell positions.
Hence, there is a restriction in the sense that the optimization can only use pre-determined catheter positions. In the so ware many catheters can be placed, but in a real patient it is desirable to have catheters not too close to each other to avoid complications. In order to have both a large enough search space for interesting rst results and a set of con gurations in which catheters are not too close to each other, we chose the set of possible con gurations to consist of 30 catheters for each patient.
e
MODEL-BASED MULTI-OBJECTIVE MIXED-INTEGER EVOLUTIONARY ALGORITHM
In this section we summarize key concepts and terminology pertaining to mixed-integer and multi-objective optimization and provide an overview and summary of GAMBIT, and introduce the MultiObjective GAMBIT (MO-GAMBIT).
Terminology

Mixed-integer optimization.
A mixed-integer problem is de ned as follows:
Here, x represents the solution
where d i ∈ {0, 1}, c i ∈ R, and x d , x c are the groups of all discrete and real-valued variables, respectively. l d and l c represent the number of discrete and continuous variables. Moreover, f is the objective function, and h and g are the sets of equality and inequality constraint functions, respectively. If both sets are empty, the mixed-integer problem is said to be unconstrained. e Pareto-optimal set P S of the problem at hand is the set of all Pareto-optimal solutions. e Pareto-optimal front P F is the set of the objective value vectors of all Pareto-optimal solutions. e goal of MO optimization is to nd a set of non-dominated solutions whose objective value vectors constitute a good approximation of the Pareto-optimal front [4] .
GAMBIT
GAMBIT is a recently introduced EA aimed at solving mixed-integer problems, especially in the black-box se ing. Here, we give a brief outline of GAMBIT. More details can be found in literature [12] . GAMBIT is a parameter-free model-based EA capable of learning and exploiting di erent types of variable dependencies, through a clustering mechanism and an integrated dependency-models mechanism. e ability to learn such dependencies (i.e., which groups of variables have a joint synergistic e ect on a solution's quality) allows for the creation of variable subsets which represent important building blocks of the problem.
ese building blocks can be used to exploit problem structure and generate new and be er solutions more e ectively. Such exploitation of problem structure based on dependencies is well-established for discrete and continuous variables, respectively. Mixed-integer optimization introduces new optimization challenges, however. e existence of discrete and continuous variables creates a potential for intra-and intervariable dependencies that domain-speci c model-based EAs are not equipped to handle. GAMBIT therefore introduces a new way to learn and process mixed inter-domain variable dependencies, alongside intra-domain dependencies (i.e., in individual domains) during optimization.
GAMBIT splits the population in each generation with the use of a clustering algorithm as detailed in Figure 2 . Each of the subpopulations acquired is then subject to variation through the integrated dependency models mechanism, summarized in pseudo-code in Figure 3 . Speci cally, a Family-Of-Subsets (FOS) model is learned at the beginning of every generation, which is used to describe dependencies and to create o spring solutions [13] . Essentially, a FOS is a set of linkage sets. Each linkage set contains the indices of the variables that are considered to be dependent. e linkage sets may overlap. e FOS consists of three types of subsets: discrete, continuous, and mixed. In its full black-box optimization con guration discrete subsets are generated using a so-called linkage tree, which is a speci c type of FOS that was rst used in the algorithm known as Linkage Tree Genetic Algorithm (LTGA), which is now considered to be an instance of the Gene-pool Optimal Mixing Evolutionary Algorithm (GOMEA) family [13] . e linkage tree is a FOS structure acquired by building from the bo om up (i.e., starting with singleton subsets of problem variables) a tree of subsets by means of a hierarchical clustering algorithm based on mutual information between pairs of variables. e linkage tree has 2l d − 1 discrete subsets representing important building blocks in the discrete domain. e same number of continuous subsets are added to the FOS, each containing every continuous problem variable. Additionally, l c + l d mixed subsets are added to the FOS by building another linkage tree constrained to merge discrete and continuous variables using a mixed mutual information metric, described in detail in [12] . Such mixed subsets allow for the consideration of discrete and continuous variables together, resulting in the ability to exploit potential mixed variable dependencies. Each type of subset is processed with a corresponding mechanism type to generate new solutions. Once all subsets are processed, new solutions replace the previous population and the clustering process begins anew.
GAMBIT Overview
Figure 2: Pseudo-code overview of GAMBIT. P represents the population of size n. C contains k cluster (also called subpopulation) centers. P i represents the i-th sub-population and O i is the o spring generated from sub-population P i .
Integrated Model Mechanism for a sub-population 
Multi-Objective GAMBIT
In this paper we introduce MO-GAMBIT that brings the blackbox mixed-integer optimization capabilities of GAMBIT into the MO domain. e approach to handle MO problem landscapes with GAMBIT is to include mechanisms designated speci cally to exploit the multi-objective nature of the problem landscape, such as an elitist archive and the ability to rank solutions in a multi-objective space. In this section, we outline the key components used in the design of MO-GAMBIT and its speci c application to brachytherapy pre-treatment planning.
Elitist Archive.
In previous work on multi-objective EAs, elitism has been shown to be very important [3] . For this reason, an elitist archive is added in MO-GAMBIT. Because real-valued variables are involved, we use a technique that adaptively changes the grid that governs the elitist archive so as to harbor a prede ned maximum number of solutions, preventing occurrences of very similar solutions in the archive while promoting diversity. For more details, see [10] .
Selection and
Variation. e selection and variation mechanisms are changed in MO-GAMBIT to account for the MO nature of the problems, and to make use of the elitist archive. Solutions are still clustered at every generation, however clustering is performed in the objective space. is allows MO-GAMBIT to specialize model-based optimization in di erent areas of the Pareto front. Variation proceeds by improving existing solutions, as is reminiscent of GOMEA, in case of discrete and mixed linkage sets. Solution parts are copied from donors and mixed into solutions, and changes are only accepted in case of a multi-objective improvement. Continuous variables are supplied from normal distributions estimated from a population-based MO rank-based selection [3] following procedures of the real-valued EDA known as iAMaLGaM [2] and its multi-objective counterpart iMAMaLGaM [1] . For an overview in pseudo-code, see Figure 3 .
Upon sampling new solutions, the clusters are populated with solutions from the previous generation as well as a fraction of τ = 0.35 elitist archive solutions that are closest to the given cluster in the objective space, using a Euclidean distance metric. If not enough elitist archive solutions exist, the entire archive is used for each cluster. is combination of solutions from the previous generation and the elitist archive is used to estimate and sample new solutions. Previously, in MO versions of GOMEA and iAMaLGaM this was found to have a positive e ect on convergence to highquality solutions [1, 10] .
Population and Cluster
Sizing. Determining parameters such as the population size or number of clusters can be crucial for the e ectiveness of EAs. Small population sizes or insu cient number of clusters can lead to premature convergence. Conversely, too many clusters or too large population sizes can result in a very large overhead. To avoid the need to specify these parameters, MO-GAMBIT adapts a interleaved multistart scheme, which dynamically introduces larger population sizes. Speci cally, the scheme runs di erently sized instances of GAMBIT in an interleaved fashion. For every γ = 2 generations of a certain instance of GAMBIT, one generation of an instance of GAMBIT with twice the population size and one more cluster is performed. By doing so, smaller population sizes perform more generational steps than larger ones. e scheme already used with GAMBIT is altered to make use of the elitist archive. With GAMBIT, all the di erently sized instances are completely independent of each other. In MO-GAMBIT the elitist archive is shared over all instances, allowing to transfer knowledge about high-quality solutions already obtained with the smaller populations.
Problem-Specific Knowledge.
A strictly black-box optimization algorithm may be a great starting point when considering new problems. In a real-world se ing however, some problemspeci c information can potentially improve performance. In our case consider that every discrete variable d 0 , d 1 , ..., d l d −1 is associated with an independent set of dwell positions. Instead of learning mixed-variable dependencies, which could result in a signi cant overhead, a pre-de ned mixed-variable subset structure is de ned that captures key dependencies. Speci cally, each subset contains one discrete variable (representing the catheter) and the set of continuous variables that represent the dwell positions associated with this catheter. Moreover, because we do not expect strong dependencies to exist between continuous variables, we do not model them jointly in one linkage set as per default in GAMBIT, but rather model them independently, i.e., univariately to reduce substantially the overhead of sampling high-dimensional Gaussian distributions.
3.3.5 Sliced 3-objective optimization. We minimize the number of catheters in one of the objectives. However, we slice this 3-dimensional problem into many 2-dimensional multi-objective problems. Li le relation between con gurations with di erent numbers of catheters exists, and switching a catheter on (i.e., changing a binary variable from 0 to 1) has huge impact, implying there exist big jumps in the search space across di erent numbers of catheters, making a direct 3-objective optimization approach extra di cult. A sliced approach allows an instance of GAMBIT to focus on con gurations with the same number of catheters, while at the same time making it easier to parallelize the optimization across con gurations with di erent number of catheters. We refer to our approach as a multi-layer approach, where in a given layer only combinations with the of number of catheters are allowed. Because solutions resulting in a di erent numbers of catheters can be created in variation, a simple random repair mechanism is used to activate or deactivate a required number of catheters.
EXPERIMENTS 4.1 Setup
Clinical data from three recently treated patients is used for optimization. For each patient, there are 30 possible catheter locations, resulting in 30 MO-GAMBIT instances, each performing optimization on a 2-objective mixed-integer problem. e duration of optimization for each MO-GAMBIT instance is limited to 48 hours (on an AMD Opteron(tm) Processor 6386 SE and Intel(R) Xeon(R) CPU E5 2699 v4), with all 30 con gurations executed in parallel. During the optimization 20,000 randomly chosen dose calculation points are used to compute the objective values for every function evaluation. To ensure su cient accuracy in reporting nal outcomes, the nal set of solutions on the Pareto front is re-evaluated with 100,000 dose calculation points, which is commonly considered to be su ciently accurate.
Results
Results in Figure 4 illustrate the quality of solutions which can be acquired with di erent numbers of catheters. e results provide a clear illustration of the trade-o s between the objectives. A solution that satis es clinical protocol lies in the area of the Pareto front where LCI ≥ 0.95 while LSI ≥ 0.75. e clinically approved solutions for the considered patients all used 16 catheters. Figure 4 shows that it is possible to obtain approvable, high-quality plans using smaller numbers of catheters. Very li le quality of solutions is lost when using a few less catheters. Only when many less catheters are used (less than 9 for the tested patients) the resulting solutions lead to clearly inferior and unacceptable plans when considering the other two objectives.
Outcomes still di er widely between patients. More solutions with be er objective values are found for patient 2. Increasing the number of catheters for patient 2 provides bigger bene ts in terms of the LCI and LSI objectives than for patient 1. is suggests that plan optimization can substantially di er for di erent patients, further highlighting the potential bene ts of enabling insight into possible trade-o s and especially the added value of considering the number of catheters as part of optimization.
When the number of catheters is small, the addition of catheters can substantially improve the trade-o s between target coverage and organ sparing (e.g., see the gap between the 2D Pareto fronts of using less vs more than 5 catheters). However, when the number of catheters is su cient, the trade-o improvement due to adding more catheters clearly diminishes. It would be interesting for future work to investigate the marginal added value of each catheter insertion with respect to the (2D) Pareto-front improvement when considering a larger patient group. e severity of trade-o s between the LCI and LSI is much higher in the more extreme regions of the Pareto front. For example, at the area where LCI is larger than 0.95, trying to increase target coverage can quickly worsen the sparing of OARs. On the other hand, if a treatment plan of LCI = 0.95 is satis able, the healthy tissues can be considerably spared from radiation risks (e.g., compare the high value of LSI of solutions having LCI = 0.95). is is very likely part of the notorious practical hardness of deciding upon what values for a good plan to ultimately use. Figure 5 illustrates selected plans obtained with MO-GAMBIT with only 10, 12 and 16 catheters for patients 1, 2 and 3 respectively. All DVH indices satisfy the clinical constraints. For these plans a doctor can decide whether it is acceptable, or whether a factor should be improved at the expense of another factor. For example, it may be desirable to use less than 12 catheters for patient 2, even with worse target coverage (but still satisfying all constraints). From the complete set of Pareto optimal solutions, a candidate plan in that trade-o direction can be taken, for which the same decision can be made, until nally the best Pareto-optimal solution is chosen without optimization needing to be re-ran.
DISCUSSION AND CONCLUSIONS
is paper considers BT treatment pre-planning optimization from a multi-objective perspective, while combining, for the rst time, a true multi-objective optimization approach with optimization directly on clinical evaluation criteria and considering trade-o s between key objectives: the covering of targets, the sparing of organs at risk, and the number of catheters. In current medical practice devising such plans depends heavily on the expertise of doctors. We wish to assist them by enabling the ability to view and consider a set of approximated Pareto optimal solutions with respect to the aforementioned objectives. With this ability, doctors may gain additional insight into possible treatment plans, potentially resulting in improved patient care. As a rst proof of concept to this end, we combined real-world clinical so ware with a novel extension of GAMBIT to multi-objective optimization.
e generated three-objective Pareto fronts for real-world patients provided a useful overview of possible treatment plans with respect to the number of catheters used, potential risk to healthy organs, and the coverage of the targets. Including, for the rst time, the number and location of possible catheters placements with a multi-objective optimization approach allowed us to gain new, clinically relevant insight into BT pre-planning optimization. We were able to obtain sets of clinically acceptable non-dominated solutions, and indicated that it appears possible to obtain good solutions with smaller numbers of catheters compared to the clinically used plans for the tested patients. Using a larger number of catheters can lead to be er, clinically acceptable solutions in terms of the other objectives, but the added value in key DVH indices used to evaluate plans strongly diminishes when using more than around 10 catheters. Outcomes further present insights into tradeo s between other key objectives, allowing doctors to utilize their expertise, and consider which of such trade-o s may be bene cial to the patient without re-running optimization.
Our approach based on MO-GAMBIT provides a new, promising and insightful approach for optimization of BT treatment plans, but further improvements to this approach are needed and possible. Optimization mechanisms which consider problem structure speci cs such as evaluation decomposability could potentially improve optimization speed substantially. Combined with other problem-speci c mechanisms, such as a multi-resolution approach to increasing the accuracy of dose calculations over time, a manyfold speedup may be obtained, reducing required run times to minutes rather than hours (even though in the pre-planning phase this is far less of an issue than when making treatment plans a er physical catheter placement has taken place) and allowing for more exhaustive exploration of the search space, potentially leading to discovery of even more high-quality non-dominated solutions. 
